Facebook Linkedin RSS Twitter Youtube
Home 2024

Wegovy

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration
Drug Discovery

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk
Drug Discovery

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus
Bioprocessing

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Industry News

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration

StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Drug Discovery

StockWatch: Amgen Throws Its Weight Behind Obesity Drug

Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Bioprocessing

Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett

Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B
Bioprocessing

Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030
Drug Discovery

StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Drug Discovery

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.